Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01892540 · ClinicalTrials.gov registry record · NA
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT01892540 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 43 participants.
The verdict
NCT01892540, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
This clinical trial studies positron emission tomography (PET)/computed tomography (CT) or PET/magnetic resonance imaging (MRI) in measuring tumors in patients undergoing clinical imaging or with newly diagnosed breast cancer. New diagnostic procedures, such as PET/CT or PET/MRI, may be more effective than MRI alone in measuring tumors in patients undergoing clinical imaging or with newly diagnosed breast cancer.
Interventions
- DIAGNOSTIC_TEST PET/MRI
- DIAGNOSTIC_TEST positron emission tomography/computed tomography
- DEVICE Position Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2013-05 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01892540
The ClinicalTrials.gov registry entry for NCT01892540 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PET/MRI is the first listed.
NCT01892540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01892540 about?
NCT01892540 is a clinical study titled "PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer". This clinical trial studies positron emission tomography (PET)/computed tomography (CT) or PET/magnetic resonance imaging (MRI) in measuring tumors in patients undergoing clinical imaging or with newly diagnosed breast cancer. New diagnostic procedures, such as PET/CT or PET/MRI, may be more effecti...
What is the current status of trial NCT01892540?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2013-05. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01892540?
The interventions under investigation include: PET/MRI (DIAGNOSTIC_TEST), positron emission tomography/computed tomography (DIAGNOSTIC_TEST), Position Device (DEVICE).
Who is sponsoring clinical trial NCT01892540?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.